MENU

<img width="600" height="120" src="https://compliance-calendar.sakiyomi.co.jp/wp-content/uploads/2023/08/logo-c-calendar-600x120-gold-2.png" alt="Compliance Calendar" class="c-headLogo__img" srcset="https://compliance-calendar.sakiyomi.co.jp/wp-content/uploads/2023/08/logo-c-calendar-600x120-gold-2.png 600w, https://compliance-calendar.sakiyomi.co.jp/wp-content/uploads/2023/08/logo-c-calendar-600x120-gold-2-300x60.png 300w" sizes="(max-width: 959px) 50vw, 800px" decoding="async" loading="eager" >

<img width="600" height="120" src="https://compliance-calendar.sakiyomi.co.jp/wp-content/uploads/2023/08/logo-c-calendar-600x120-gold-2.png" alt="Compliance Calendar" class="c-headLogo__img" srcset="https://compliance-calendar.sakiyomi.co.jp/wp-content/uploads/2023/08/logo-c-calendar-600x120-gold-2.png 600w, https://compliance-calendar.sakiyomi.co.jp/wp-content/uploads/2023/08/logo-c-calendar-600x120-gold-2-300x60.png 300w" sizes="(max-width: 959px) 50vw, 800px" decoding="async" loading="eager" >

EU｜EMA、レバミゾール製剤の販売承認の撤退を勧告

https://www.ema.europa.eu/en/news/ema-recommends-withdrawal-marketing-authorisations-levamisole-medicines

Tags: EU｜欧州連合

Date

2026年 2月 13日

Expired!

Time

All Day

Labels

公布/公表

Category

セクター

化学物質

医療・医薬品

医薬品

コメント